Peer Review History
| Original SubmissionAugust 28, 2024 |
|---|
|
PONE-D-24-37218Predicting Dietary Management Intention of Patients with Chronic Kidney Disease Using Protection Motivation TheoryPLOS ONE Dear Dr. Huang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Prathap kumar Simhadri, MD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript. 3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Comments from the Editor- Thank you for submitting the interesting manuscript, and our decision at this time is to " revise the manuscript". Please address all the questions raised by the reviewers and resubmit the revised manuscript. Please clarify the parameters of the variables mentioned in the Table 1. (Weight in pounds or kilograms, Height in inches, please provide the dollar equivalent of the currency mentioned etc.) Reviewer 1. The manuscript is very interesting, it assesses a fundamental aspect of the treatment of patients with CKD. In my opinion, it would be more intuitive for the reader to insert a table with the items evaluated by the questionnaire, rather than to report them in the text (line 119-128). Reviewer 2. I would have like to see sub analysis based on different stages of CKD as dietary restrictions are more restrictive in advanced ckd compared to CKD stage III A patients It was done only in hospitalized patients and so there is selection bias and would be benefecial to see this hypothesis done in office patients There were almost 88 % who were married and so unsure if results could be generalized, While the hypotheses are well-stated, presenting the results in a table specifically dedicated to hypothesis testing (e.g., whether each hypothesis is supported or rejected) would add clarity for readers. Reviewer 3. If the patient population had any other factors like hypertension, obesity or other cardiovascular risk factors that could make the results skewed. Otherwise the article appears to be interesting idea. Reviewer 4. The study is written in fluent English and well articulated. It is written with good flow in almost all the sections. Methods used were relevant and well conducted. Statistical analysis - did the study account for CKD stage which can inherently influence the DMI bringing in bias? weakness remains the cross-sectional nature of the study which was also mentioned in the study limitations. Overall the study offered valuable information for actionable items and also paved way for further longitudinal research to confirm as well as elaborate on the behavioral aspects behind dietary management intention. Reviewer 5. 1. Very interesting and tailored approach to enhance adherence to dietary recommendations in Chronic Kidney Disease 2. Also, I have found no similar articles 3. Small word correction on page 9, line 205, 'report' instead of 'repot' 4. I am a proponent of diet modification in CKD and agree that all the current recommendations are generalized to the Western population, especially where access to processed food it very high, which plays a significant role in worsening of several chronic diseases including Diabetes, Hypertension, Heart disease and CKD, and which are more than often interconnected. 5. I feel this study lays the foundation for future large prospective or Randomized Control Trials on this topic and encourage more researchers from different continents to use similar or different approaches to study the factors influencing dietary habits of different ethnicities so that a targeted approach can be employed to reduce the global burden of CKD and ESKD. Reviewer 6. 1) Keep the Dietary Management Intentions- consistent Not Intention in one place and intentions in other places 2) Chronic kidney disease (CKD) is a pathological condition in which a gradual loss of kidney function occurs over five stages classified by estimated glomerular filtration rate . This is a clinical classification and classified into 5 stages- needs correction 3) As patients in early stages of CKD might have few signs or symptoms, they may feel reluctant to seek and follow medical advice on managing the condition. This statement makes more sense if it says less instead of few. Also, this study seems more appropriate on an outpatient basis. Any explanation as to why this was intended to be done as inpatient [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript is very interesting, it assesses a fundamental aspect of the treatment of patients with CKD. In my opinion, it would be more intuitive for the reader to insert a table with the items evaluated by the questionnaire, rather than to report them in the text (line 119-128). Reviewer #2: I would have like to see sub analysis based on different stages of CKD as dietary restrictions are more restrictive in advanced ckd compared to CKD stage III A patients It was done only in hospitalized patients and so there is selection bias and would be benefecial to see this hypothesis done in office patients There were almost 88 % who were married and so unsure if results could be generalizedWhile the hypotheses are well-stated, presenting the results in a table specifically dedicated to hypothesis testing (e.g., whether each hypothesis is supported or rejected) would add clarity for readers. Reviewer #3: If the patient population had any other factors like hypertension, obesity or other cardiovascular risk factors that could make the results skewed. Otherwise the article appears to be interesting idea. Reviewer #4: The study is written in fluent English and well articulated. It is written with good flow in almost all the sections. Methods used were relevant and well conducted. Statistical analysis - did the study account for CKD stage which can inherently influence the DMI bringing in bias? weakness remains the cross-sectional nature of the study which was also mentioned in the study limitations. Overall the study offered valuable information for actionable items and also paved way for further longitudinal research to confirm as well as elaborate on the behavioral aspects behind dietary management intention. Reviewer #5: 1. Very interesting and tailored approach to enhance adherence to dietary recommendations in Chronic Kidney Disease 2. Also, I have found no similar articles 3. Small word correction on page 9, line 205, 'report' instead of 'repot' 4. I am a proponent of diet modification in CKD and agree that all the current recommendations are generalized to the Western population, especially where access to processed food it very high, which plays a significant role in worsening of several chronic diseases including Diabetes, Hypertension, Heart disease and CKD, and which are more than often interconnected. 5. I feel this study lays the foundation for future large prospective or Randomized Control Trials on this topic and encourage more researchers from different continents to use similar or different approaches to study the factors influencing dietary habits of different ethnicities so that a targeted approach can be employed to reduce the global burden of CKD and ESKD. Reviewer #6: 1) Keep the Dietary Management Intentions- consistent Not Intention in one place and intentions in other places 2) Chronic kidney disease (CKD) is a pathological condition in which a gradual loss of kidney function occurs over five stages classified by estimated glomerular filtration rate . This is a clinical classification and classified into 5 stages- needs correction 3) As patients in early stages of CKD might have few signs or symptoms, they may feel reluctant to seek and follow medical advice on managing the condition. This statement makes more sense if it says less instead of few. Also, this study seems more appropriate on an outpatient basis. Any explanation as to why this was intended to be done as inpatient ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: Yes: Babu Sriram Maringanti Reviewer #5: Yes: Vikas Vujjini Reviewer #6: Yes: Hari Naga Garapati ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-24-37218R1Predicting dietary management intention of patients with chronic kidney disease using protection motivation theoryPLOS ONE Dear Dr. Huang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for revising the manuscript and it needs further minor revision before it can be accepted. Please verify the parameters of the variables mentioned in the parenthesis for the Table 1 and resubmit the revised manuscript. Please submit your revised manuscript by Mar 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Prathap kumar Simhadri, MD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Thank you for revising the manuscript and addressing all the questions raised by the reviewers. The parameters mentioned in the parenthesis for the variables Height and Weight need to be revised. Please revise the manuscript further before it could be accepted. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Predicting dietary management intention of patients with chronic kidney disease using protection motivation theory PONE-D-24-37218R2 Dear Dr. Huang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Prathap kumar Simhadri, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-37218R2 PLOS ONE Dear Dr. Huang, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Prathap kumar Simhadri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .